Bristol Myers Squibb get EC approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) with chemotherapy for metastatic NSCLC Read more
Xeris Pharma gets US FDA fast track designation for diazepam non-aqueous injection to treat acute repetitive seizures Read more